EX-99.1 2 exhibit991-8xkq322earnings.htm EX-99.1
Exhibit 99.1
EXPENSIFY ANNOUNCES Q3 2022 RESULTS
Business fundamentals remain strong. Company announces plan for additional $6 million in near-term share repurchases, for an expected total of $10 million for FY22 including net settling equity awards.
PORTLAND, Ore.--(BUSINESS WIRE)--November 10, 2022-- Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards and bills, today announced results for its quarter ended September 30th, 2022.
"The business is doing great and we’re methodically executing our long-term strategy but the economy sucks, especially for SMBs. We have seen tons of interest in the new payroll launch, and we're super excited about what we've got cooking up in the lab," said David Barrett, founder and CEO. "We stand behind our multi-year revenue guidance, with the caveat that hitting this requires the world to return to normalcy – which we think it will soon, but your guess is as good as ours, The waters are a lot choppier than anybody would like, but we believe all of the contributing factors to this volatility are temporary, so we aren't letting them distract us. I contribute 100% of my salary to the ESPP and the company is actively buying back company stock, so we couldn't be more bullish on the future."
"Despite economic headwinds, we continue to show that Expensify is a strong business able to generate positive cash flow in challenging economic environments,". said Ryan Schaffer, Expensify's CFO. "This quarter we saw modest user growth, with revenue slightly down due to a simplification of subscription management for our accounting partners to streamline client management. We repurchased $4 million in shares in Q3 via net settling equity incentive awards that vested and intend to continue taking advantage of the volatility in the market by repurchasing an additional $6 million starting at market open tomorrow morning."
Third Quarter 2022 Highlights
Financial:
•Revenue was $42.5 million, an increase of 13% compared to the same period last year.
•Net cash used by operating activities was $(0.9) million.
◦The timing of customer settlement funds was the primary driver in decreasing operating cash flow this quarter. Removing customer funds and considering only funds generated by the business gives a Free cash flow of $4.7 million.
•Net loss was $8.2 million, compared to $6.3 million for the same period last year. Q3 22's loss was primarily driven by stock-based compensation expenses of $13.4 million.
◦Non-GAAP net income was $5.1 million.
◦Stock-based compensation is expected to decrease going forward. See stock based compensation schedule below for further details.
•Adjusted EBITDA was $9.0 million, with an Adjusted EBITDA margin of 21%.
•Interchange derived from the Expensify Card grew to $1.9 million, an increase of 115% compared to the same period last year.
Business
•Paid members - Paid members grew to 761,000, an increase of 14% from the same period last year.
•Buyback - The company previously announced it had obtained authorization to repurchase $50M in shares. In Q3, $4M was spent on net share settlement of RSUs, and the company announced its plans to begin repurchasing a further $6M at market open on November 11, 2022.

Exhibit 99.1
•Payroll - Began on-boarding beta customers to Expensify Payroll, with a significant waitlist of interested customers.
•New Pricing for Accountants - In addition to the Expensify CPA Card and preferred pricing, accounting firms that join the Expensify Approved! Accountants program now receive flexible subscription management and a dedicated account manager for them and their clients.
•New Account Managers - Top 41% of customers (by revenue) now have a dedicated account manager. The remaining 59% are being evaluated for account managers in the near future.
•Free Plan - More than 15,000 businesses are now using the Expensify Free Plan, which offers corporate cards, expense management, invoicing, and bill payment at no cost.
Financial Outlook
Expensify's outlook statements are based on current estimates, expectations and assumptions and are not a guarantee of future performance. The following statements are forward-looking and actual results could differ materially depending on market conditions and the factors set forth under “Forward-Looking Statements” below. There can be no assurance that the Company will achieve the results expressed by this guidance.
We reaffirm our long term guidance provided in connection with our fourth quarter 2021 results of 25-35% revenue growth over a multi-year period, which assumes an eventual return to normalcy of the world economy.
Expensify is also providing an estimate on what stock based compensation is expected to look like for the next four fiscal quarters. Driven primarily by the pre-IPO grant of RSUs issued to all employees (which quarterly vest over 8 years with approximately 7 years remaining), stock based compensation is estimated as seen below:
Est. stock-based compensation (millions)

| Q4 2022 |  | Q1 2023 |  | Q2 2023 | Q3 2023
| Low |  | High |  | Low |  | High |  | Low |  | High | Low |  | High
Cost of revenue, net | $ | 3.6 |  |  | $ | 4.3 |  |  | 3.4 |  | $ | 4.1 |  |  | $ | 3.3 |  |  | $ | 4.0 |  | $ | 3.3 |  |  | $ | 3.9 |
Research and development | 1.5 |  |  | 1.8 |  |  | 1.4 |  | 1.7 |  |  | 1.4 |  |  | 1.7 |  | 1.3 |  |  | 1.6 |
General and administrative | 3.6 |  |  | 4.3 |  |  | 3.4 |  | 4.1 |  |  | 3.3 |  |  | 4.0 |  | 3.2 |  |  | 3.9 |
Sales and marketing | 1.7 |  |  | 2.0 |  |  | 1.6 |  | 1.9 |  |  | 1.5 |  |  | 1.8 |  | 1.5 |  |  | 1.8 |
Total | $ | 10.4 |  |  | $ | 12.4 |  |  | $ | 9.8 |  |  | $ | 11.8 |  |  | $ | 9.5 |  |  | $ | 11.5 |  | $ | 9.3 |  |  | $ | 11.2 |

Availability of Information on Expensify’s Website
Investors and others should note that Expensify routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Expensify Investor Relations website at https://ir.expensify.com. While not all of the information that the Company posts to its Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Expensify to review the information that it shares on its Investor Relations website.
Conference Call
Expensify will host a video call to discuss the financial results and business highlights at 2:00 p.m. Pacific Time today. An investor presentation and the video call information is available on Expensify’s Investor Relations website at https://ir.expensify.com. A replay of the call will be available on the site for three months.
Non-GAAP Financial Measures

Exhibit 99.1
In addition to financial measures prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), we provide certain non-GAAP financial measures, including adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, and free cash flow.
We believe our non-GAAP financial measures are useful in evaluating our business, measuring our performance, identifying trends affecting our business, formulating business plans and making strategic decisions. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team. These non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled metrics or measures presented by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business. A reconciliation of each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP is at the end of this press release.
Adjusted EBITDA. We define adjusted EBITDA as net income from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization and stock based compensation.
Adjusted EBITDA margin. We define adjusted EBITDA margin as adjusted EBITDA divided by total revenue for the same period.
Non-GAAP net income. We define non-GAAP net income as net income from operations in accordance with US GAAP excluding stock-based compensation and IPO-related bonus costs. Prior to the fourth quarter of 2021, this metric only excluded IPO-related bonus costs and did not exclude expenses related to stock-based compensation. However, management now believes that further excluding stock-based compensation from non-GAAP net income is useful to better understand the financial performance of our business and to facilitate a better comparison of our results to those of peer companies over multiple periods given that this item may vary between companies for reasons unrelated to overall operating performance. IPO-related bonus costs impacted the second, third and fourth fiscal quarters of 2021 but did not impact the first or second quarters of 2022 and are not expected to impact future periods.
Non-GAAP net income margin. We define non-GAAP net income as non-GAAP net income divided by total revenue for the same period.
Free cash flow. We define Free cash flow as net cash (used in) provided by operating activities excluding changes in settlement assets and settlement liabilities, which represent funds held for customers and customer funds in transit, respectively, reduced by the purchases of property and equipment and software development costs.
The tables at the end of the Condensed Consolidated Financial Statements provide reconciliations to the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.
Forward-Looking Statements
Forward-looking statements in this press release, or made during the earnings call, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955. These statements include statements regarding our strategy, future financial condition, future operations, projected costs,

Exhibit 99.1
prospects, plans, objectives of management and expected market growth, our ability to meet our long-term guidance, the amount and timing of any share repurchases, our stock-based compensation estimates and the timing of when we expect the economy to return to normalcy and involve known and unknown risks that are difficult to predict. As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “objective,” “seeks,” "outlook," or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the impact on inflation on us and our members; our borrowing costs have and may continue to increase as a result of increases in interest rates; our expectations regarding our financial performance and future operating performance; our ability to attract and retain members, expand usage of our platform, sell subscriptions to our platform and convert individuals and organizations into paying customers; the timing and success of new features, integrations, capabilities and enhancements by us, or by competitors to their products, or any other changes in the competitive landscape of our market; the amount and timing of operating expenses and capital expenditures that we may incur to maintain and expand our business and operations to remain competitive; the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs; our ability to make required payments under and to comply with the various requirements of our current and future indebtedness; our cash flows, the prevailing stock prices, general economic and market conditions and other considerations that could affect the specific timing, price and size of repurchases under our stock repurchase program or our ability to fund any stock repurchases; the war in Ukraine and escalating geopolitical tensions as a result of Russia's invasion of Ukraine; our ability to effectively manage our exposure to fluctuations in foreign currency exchange rates; the increased expenses associated with being a public company; the size of our addressable markets, market share and market trends; anticipated trends, developments and challenges in our industry, business and the highly competitive markets in which we operate; our expectations regarding our income tax liabilities and the adequacy of our reserves; our ability to effectively manage our growth and expand our infrastructure and maintain our corporate culture; our ability to identify, recruit and retain skilled personnel, including key members of senior management; the safety, affordability and convenience of our platform and our offerings; our ability to successfully defend litigation brought against us; our ability to successfully identify, manage and integrate any existing and potential acquisitions of businesses, talent, technologies or intellectual property; general economic conditions in either domestic or international markets; our protections against security breaches, technical difficulties, or interruptions to our platform; our ability to maintain, protect and enhance our intellectual property; and other risks discussed in our filings with the SEC. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. We caution you not to place undue reliance on any forward-looking statements, which are made only as of the date of this press release. We do not undertake or assume any obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable law. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
About Expensify
Expensify is a payments superapp that helps individuals and businesses around the world simplify the way they manage money. More than 12 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app. All free. Whether you own a small business, manage a team, or close the books for your clients, Expensify makes it easy so you have more time to focus on what really matters.
Investor Relations Contact
Nick Tooker
investors@expensify.com
Press Contact

Exhibit 99.1
James Dean
press@expensify.com

Expensify, Inc.
Condensed Consolidated Balance Sheets
(unaudited, in thousands, except share and per share data)

| As of September 30, |  | As of December 31,
| 2022 |  | 2021
Assets |  |  |
Cash and cash equivalents | $ | 106,212 |  |  | $ | 98,398 |
Accounts receivable, net | 16,274 |  |  | 15,713 |
Settlement assets | 39,359 |  |  | 21,880 |
Prepaid expenses | 5,698 |  |  | 7,436 |
Related party loan receivable | — |  |  | 14 |
Other current assets | 21,247 |  |  | 14,201 |
Total current assets | 188,790 |  |  | 157,642 |
Capitalized software, net | 6,142 |  |  | 6,359 |
Property and equipment, net | 14,872 |  |  | 15,930 |
Lease right-of-use assets | 1,109 |  |  | 2,202 |
Deferred tax assets, net | 200 |  |  | 370 |
Other assets | 580 |  |  | 710 |
Total assets | $ | 211,693 |  |  | $ | 183,213 |
Liabilities and stockholders' equity |  |  |
Accounts payable | $ | 2,177 |  |  | $ | 3,752 |
Accrued expenses and other liabilities | 7,862 |  |  | 11,046 |
Borrowings under line of credit | 15,000 |  |  | 15,000 |
Current portion of long-term debt, net of original issuance discount and debt issuance costs | 549 |  |  | 549 |
Lease liabilities, current | 1,190 |  |  | 1,549 |
Settlement liabilities | 36,383 |  |  | 21,680 |
Total current liabilities | 63,161 |  |  | 53,576 |
Lease liabilities, non-current | — |  |  | 802 |
Other liabilities | 1,145 |  |  | 153 |
Long-term debt, net of original issuance discount and debt issuance costs | 51,572 |  |  | 52,067 |
Total liabilities | 115,878 |  |  | 106,598 |
Commitments and contingencies (Note 4) |  |  |
Stockholders' equity: |  |  |
Common stock, par value $0.0001; 1,000,000,000 shares of Class A common stock authorized as of September 30, 2022 and December 31, 2021; 68,575,385 and 67,844,060 shares of Class A common stock issued and outstanding as of September 30, 2022 and December 31, 2021, respectively; 24,997,561 and 25,000,000 shares of LT10 common stock authorized as of September 30, 2022 and December 31, 2021, respectively; 7,336,191 and 7,332,640 shares of LT10 common stock issued and outstanding as of September 30, 2022 and December 31, 2021, respectively; 24,999,170 and 25,000,000 shares of LT50 common stock authorized as of September 30, 2022 and December 31, 2021, respectively; 6,732,693 and 6,224,160 shares of LT50 common stock issued and outstanding as of September 30, 2022 and December 31, 2021, respectively; preferred stock, par value $0.0001; 10,000,000 shares of preferred stock authorized as of September 30, 2022 and December 31, 2021; no shares of preferred stock issued and outstanding as of September 30, 2022 and December 31, 2021 | 7 |  |  | 6 |
Additional paid-in capital | 185,326 |  |  | 142,515 |
Accumulated deficit | (89,518) |  |  | (65,906) |
Total stockholders' equity | 95,815 |  |  | 76,615 |
Total liabilities and stockholders' equity | $ | 211,693 |  |  | $ | 183,213 |

Expensify, Inc.
Condensed Consolidated Statements of Operations
(unaudited, in thousands, except share and per share data)

| Three months ended September 30, |  | Nine months ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
| (in thousands, except per share data)
Revenue | $ | 42,493 |  |  | $ | 37,447 |  |  | $ | 126,026 |  |  | $ | 102,471 |
Cost of revenue, net(1) | 16,554 |  |  | 18,197 |  |  | 46,564 |  |  | 33,768 |
Gross margin | 25,939 |  |  | 19,250 |  |  | 79,462 |  |  | 68,703 |
Operating expenses: |  |  |  |  |  |  |
Research and development(1) | 3,416 |  |  | 2,167 |  |  | 10,701 |  |  | 8,138 |
General and administrative(1) | 15,898 |  |  | 18,333 |  |  | 45,335 |  |  | 35,827 |
Sales and marketing(1) | 12,342 |  |  | 7,608 |  |  | 37,958 |  |  | 14,555 |
Total operating expenses | 31,656 |  |  | 28,108 |  |  | 93,994 |  |  | 58,520 |
(Loss) income from operations | (5,717) |  |  | (8,858) |  |  | (14,532) |  |  | 10,183 |
Interest and other expenses, net | (2,369) |  |  | (1,054) |  |  | (5,226) |  |  | (2,560) |
(Loss) income before income taxes | (8,086) |  |  | (9,912) |  |  | (19,758) |  |  | 7,623 |
Provision for income taxes | (156) |  |  | 3,567 |  |  | (3,854) |  |  | 706 |
Net (loss) income | $ | (8,242) |  |  | $ | (6,345) |  |  | $ | (23,612) |  |  | $ | 8,329 |
Less: income allocated to participating securities | — |  |  | — |  |  | — |  |  | (5,625) |
Net (loss) income attributable to Class A, LT10 and LT50 common stockholders | $ | (8,242) |  |  | $ | (6,345) |  |  | $ | (23,612) |  |  | $ | 2,704 |
Net (loss) income per share attributable to Class A, LT10 and LT50 common stockholders: |  |  |  |  |  |  |
Basic | $ | (0.10) |  |  | $ | (0.18) |  |  | $ | (0.29) |  |  | $ | 0.09 |
Diluted | $ | (0.10) |  |  | $ | (0.18) |  |  | $ | (0.29) |  |  | $ | 0.07 |
Weighted-average shares of common stock used to compute net (loss) income per share attributable to Class A, LT10 and LT50 common stockholders: |  |  |  |  |  |  |
Basic | 80,941,664 |  |  | 34,490,860 |  |  | 80,523,557 |  |  | 31,301,387 |
Diluted | 80,941,664 |  |  | 34,490,860 |  |  | 80,523,557 |  |  | 41,452,880 |

(1)Includes stock-based compensation expense as follows:

| Three months ended September 30, |  | Nine months ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Cost of revenue, net | $ | 4,667 |  |  | $ | 245 |  |  | $ | 14,278 |  |  | $ | 670 |
Research and development | 1,931 |  |  | 154 |  |  | 6,230 |  |  | 482 |
General and administrative | 4,624 |  |  | 410 |  |  | 15,063 |  |  | 1,118 |
Sales and marketing | 2,142 |  |  | 88 |  |  | 6,222 |  |  | 225 |
Total stock-based compensation expense | $ | 13,364 |  |  | $ | 897 |  |  | $ | 41,793 |  |  | $ | 2,495 |

Expensify, Inc.
Condensed Consolidated Statements of Cash Flows
(unaudited, in thousands)

| Nine months ended September 30,
| 2022 |  | 2021
Cash flows from operating activities: |  |  |
Net (loss) income | $ | (23,612) |  |  | $ | 8,329 |
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |  |  |
Depreciation and amortization | 4,072 |  |  | 3,732 |
Reduction of operating lease right-of-use assets | 531 |  |  | 552 |
Loss on impairment, receivables and sale or disposal of equipment | 722 |  |  | 283 |
Stock-based compensation | 41,793 |  |  | 2,495 |
Amortization of original issuance discount and debt issuance costs | 22 |  |  | 23 |
Deferred tax assets | 170 |  |  | — |
Changes in assets and liabilities: |  |  |
Accounts receivable, net | (1,016) |  |  | (3,865) |
Settlement assets | (10,096) |  |  | (3,344) |
Prepaid expenses | 1,738 |  |  | (2,886) |
Related party loan receivable | 14 |  |  | (224) |
Other current assets | 558 |  |  | 1,212 |
Other assets | 11 |  |  | 120 |
Accounts payable | (1,575) |  |  | (330) |
Accrued expenses and other liabilities | (2,195) |  |  | 18,870 |
Operating lease liabilities | (601) |  |  | (614) |
Settlement liabilities | 14,703 |  |  | 10,699 |
Other liabilities | 990 |  |  | (472) |
Net cash provided by operating activities | 26,229 |  |  | 34,580 |
Cash flows from investing activities: |  |  |
Purchases of property and equipment | (467) |  |  | (2,602) |
Software development costs | (906) |  |  | (4,397) |
Net cash used by investing activities | (1,373) |  |  | (6,999) |
Cash flows from financing activities: |  |  |
Principal payments of finance leases | (593) |  |  | (579) |
Principal payments of term loan | (445) |  |  | (25,157) |
Proceeds from term loan | — |  |  | 45,000 |
Repurchases of early exercised stock options | (25) |  |  | — |
Proceeds from common stock purchased under Matching Plan | 2,433 |  |  | — |
Payments of deferred offering costs | — |  |  | (4,796) |
Vesting of restricted common stock | — |  |  | 234 |
Proceeds from issuance of common stock on exercise of stock options | 700 |  |  | 2,862 |
Payments for employee taxes withheld from stock-based awards | (4,172) |  |  | — |
Net cash (used) provided by financing activities | (2,102) |  |  | 17,564 |
Net increase in cash and cash equivalents and restricted cash | 22,754 |  |  | 45,145 |
Cash and cash equivalents and restricted cash, beginning of period | 125,315 |  |  | 46,878 |
Cash and cash equivalents and restricted cash, end of period | $ | 148,069 |  |  | $ | 92,023 |
Supplemental disclosure of cash flow information: |  |  |
Cash paid for interest | $ | 2,721 |  |  | $ | 2,182 |
Cash paid for income taxes | $ | 879 |  |  | $ | 6,910 |
Noncash investing and financing items: |  |  |
Accrued deferred offering costs | $ | — |  |  | $ | 795 |
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets |  |  |
Cash and cash equivalents | $ | 106,212 |  |  | $ | 68,058 |
Restricted cash included in other current assets | 16,255 |  |  | 5,989 |
Restricted cash included in other assets | — |  |  | 47 |
Restricted cash included in settlement assets | 25,602 |  |  | 17,929 |
Total cash, cash equivalents and restricted cash | $ | 148,069 |  |  | $ | 92,023 |

Expensify, Inc.
Reconciliation of GAAP to Non-GAAP Financial Measures
(unaudited, in thousands, except percentages)
Adjusted EBITDA and Adjusted EBITDA Margin

| Three months ended September 30,
| 2022
Net (loss) income | $ | (8,242) |
Net (loss) income margin | (19) | %
Add: |
Provision for income taxes | 156 |
Interest and other expenses, net | 2,369 |
Depreciation and amortization | 1,323 |
Stock-based compensation | 13,364 |
Adjusted EBITDA | $ | 8,970 |
Adjusted EBITDA margin | 21 | %

Non-GAAP Net Income and Non-GAAP Net Income Margin

| Three months ended September 30,
| 2022
Net (loss) income | $ | (8,242) |
Net (loss) income margin | (19) | %
Add: |
Stock-based compensation | 13,364 |
IPO-related bonus expense | — |
Non-GAAP net income | $ | 5,122 |
Non-GAAP net income margin | 12 | %

Adjusted Operating Cash Flow and Free Cash Flow

| Three months ended September 30,
| 2022
| (in thousands)
Net cash (used in) provided by operating activities | $ | (929) |
(Increase) decrease in changes in assets and liabilities: |
Settlement assets | (1,097) |
Settlement liabilities | (5,207) |
Adjusted operating cash flow | $ | 5,375 |
Less: |
Purchases of property and equipment | (200) |
Software development costs | (438) |
Free cash flow | $ | 4,737 |